)
)
Reunion Neuroscience Investor Relations Material
Latest events
Q3 2023
Reunion Neuroscience
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Reunion Neuroscience Inc
Access all reports
Reunion Neuroscience Inc. is a biotechnology company focused on developing innovative treatments for mental health conditions, with a particular emphasis on psychedelic-inspired therapies. The company’s lead programs are aimed at addressing major depressive disorder and other mental health challenges using novel compounds derived from psychedelics. Reunion Neuroscience seeks to advance clinical research and leverage its proprietary technologies to offer new treatment options for patients where traditional therapies may have limited effectiveness. The company is headquartered in Toronto, Canada, and its shares are listed on the Nasdaq.
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
REUN
Country
🇺🇸 United States